Ординатура / Офтальмология / Английские материалы / Primary Optic Nerve Sheath Meningioma_Jeremic, Pitz_2008
.pdf
107
108 |
B. Jeremić, M. W. Wasik, S. Villà, F. Paulsen, G. Bednarz, D. Linero and M. Buchgeister |
|
|
|
|
|
MRI scans of the brain every 6 months, then every 12 |
Contrast-enhanced CT data are obtained in the frame |
|
months. |
with a localization cage attached. The patient is removed |
|
Gross Tumour Volume (GTV) was defined on MRI |
from the frame and a gadolinium enhanced MR scan is |
|
images, fused to the orbital CT scans. GTV comprised |
obtained next. Both imaging datasets are electronically |
|
the tumour alone and not the entire optic nerve. No |
transferred to the treatment planning workstation where |
|
margin was added to the GTV to create CTV or PTV. |
they are fused into one composite image for treatment |
|
Normal structures which were routinely contoured in- |
planning purposes. Due to the high spatial fidelity of |
|
cluded the optic nerves, optic chiasm, eye globes and |
CT data, the CT dataset is an obligatory imaging dataset |
|
lenses. The maximum allowed dose to the optic chiasm |
for treatment planning. The patient is discharged home |
|
was in the range of 54–57 Gy, depending on the circum- |
and returns for treatment inception usually a week to 10 |
|
stances. Dose Volume Histograms (DVH) were always |
days later. In the X-Knife system the dose is delivered by |
|
used to assess the dose distribution to the GTV and |
using the arc rotation of the linac radiation beam around |
|
normal organs. |
the linac isocenter. Beam collimation is accomplished |
|
|
using circular collimators (cones) ranging from 0.5 cm |
|
10.3.1.1.1 |
to 5 cm in diameter. For single isocenter treatment, the |
|
treatment planning relays on selecting the cone size, |
|
|
X-Knife-based SRT with Relocatable Frame |
which covers the target and placing a number of arcs |
|
and Multiple Isocenter Technique |
to deliver the radiation dose (Fig. 10.2). For irregular |
|
For X-Knife-based SRT, the pre-treatment patient prep- |
targets multiple cones, each placed at a new isocenter, |
|
can be combined to cover the target (Fig. 10.3). Adjust- |
|
|
aration involves the customized design of a lightweight |
ing the placement, lengths and weights of the arcs and |
|
relocatable frame – the Gill-Thomas-Cosman (GTC) |
the weights of the isocenters, can shape the dose cloud |
|
frame (Kooy et al. 1994) , which is a large “halo” de- |
(Fig. 10.4). |
|
vice that is attached to the patient with custom molded |
Because of the linear shape of ONSM, the X-Knife |
|
devices that fit into the oral cavity (based on dental |
treatmentPROOFSplanning and delivery necessarily involved |
|
impression of patient’s upper dentition) and conform |
multiple overlapping isocenters. This created dose inho- |
|
to the shape of the occipital region at the back of the |
D |
|
Emogeneity along the axis of the optic nerve. With the |
|
|
head (Fig. 10.1). Day-to-day accuracy of the GTC frametadvent of the Novalis unit, we have since adopted treat- |
|
|
can be verified using a special device called the “depthC |
ments based on a single isocenter which are much more |
|
conformation helmet”, a plastic hemispherical shellEthat |
efficient and which yield much higher dose homogene- |
|
allows for the measurement of the distanceRbetween |
ity along the axis of the optic nerve with dynamic arc |
|
the shell and the head surface at a numberRof locations. |
technique. |
|
CO |
|
Fig. 10.1. The Gill-Thomas-Cosman relocatable frame |
Fig. 10.2. X-Knife treatment with single collimator and mul- |
|
tiple arcs of various lengths and orientations |
978-3-540-77557-7_1_2008-08-06_1
Stereotactic Radiation Therapy in Primary Optic Nerve Sheath Meningioma |
109 |
|
|
Fig. 10.3. For irregular targets, such as ONSM, multiple cones, |
Fig. 10.4. X-Knife treatment with multiple isocenters for |
||
each placed at a new isocenter, can be combined to cover the |
ONSM. The dose cloud is shaped by adjusting the isocenters |
||
target |
|
|
weight and arcs lengths, placements and weights |
10.3.1.1.2 |
|
|
anteriorPROOFScomponents. In addition to the two anterior |
The BrainLab/Novalis SRT System |
|
|
parts, a special nose bridge is molded from thermoplas- |
with Mini-multileaf Collimator |
|
|
D |
|
|
Etic beads to minimize head rotation during reposition- |
|
|
ting. All components are mounted on a U-shaped metal |
||
Patients can be treated on the Novalis system eitherCus- |
frame and locked together with a set of plastic clips |
||
ing the GTC frame or a multi-component thermoplasE |
- |
with adjustable spacers to allow for the mask shrinkage |
|
tic head mask (BrainLab, Germany), which Ris custom- |
(Fig. 10.5a). The Novalis treatment-planning worksta- |
||
fitted to the shape of the patient’s head (GeorgR |
et al. tion provides a number of planning options ranging |
||
2006). The mask consists of one posterior shell and two |
from dynamic arc treatment, to conformal static arcs or |
||
CO |
|
|
|
N |
|
|
|
a |
b |
Fig. 10.5a,b. BrainLab’s thermoplastic head mask (a) and isodose distribution in ONSM patient (b)
978-3-540-77557-7_1_2008-08-06_1
110 |
B. Jeremić, M. W. Wasik, S. Villà, F. Paulsen, G. Bednarz, D. Linero and M. Buchgeister |
||||||||
|
|
|
|
|
|
|
|||
|
stereotactic IMRT (Solberg et al. 2001). At our insti- |
|
|
|
|
|
|||
|
|
|
|
|
|
||||
|
tution, most treatment plans involve a single isocenter |
|
|
|
|
|
|||
|
|
|
|
|
|
||||
|
treatment with five non-coplanar arcs utilizing the dy- |
|
|
|
|
|
|||
|
|
|
|
|
|
||||
|
namic arc method. With micro-multileaf collimation, |
|
|
|
|
|
|||
|
this technique allows for both high target conformality |
|
|
|
|
|
|||
|
|
|
|
|
|
||||
|
and high dose homogeneity (Fig. 10.5b). |
|
|
|
|
|
|
||
|
We published our initial results of SRT for ONSM |
|
|
|
|
|
|||
|
|
|
|
|
|
||||
|
involving 33 optic nerves in 30 patients in 2002 (An- |
|
|
|
|
|
|||
|
drews et al. 2002). The median prescription dose was |
|
|
|
|
|
|||
|
|
|
|
|
|
||||
|
51 Gy (range: 50.4–54 Gy) and the median follow-up, 21 |
|
|
|
|
|
|||
|
months. Of 22 optic nerves with vision before SRT, 20 |
|
|
|
|
|
|||
|
|
|
|
|
|
||||
|
nerves (92%) demonstrated preserved vision and 42% |
|
|
|
|
|
|||
|
manifested improvement in visual acuity and/or visual |
|
|
|
|
|
|||
|
|
|
|
|
|
||||
|
fields. Four patients (13%) had post-treatment morbidi- |
|
|
|
|
|
|||
|
ties, including visual loss (two patients), optic neuritis |
|
|
|
|
|
|||
|
|
|
|
|
|
||||
|
(one patient) and transient orbital pain (one patient). At |
|
Fig. 10.7. Early improvement in visual acuity in a patient with |
||||||
|
the time of publication, no tumour progression was re- |
|
right ONSM treated with SRT |
||||||
|
ported on MRI scans. Six patients were monitored with |
|
|
|
|
|
|||
|
111In-octreotide scintigraphy which demonstrated sig- |
|
|
|
|
|
|||
|
nificant metabolic responses following SRT. |
|
|
10.3.1.2 |
|
|
|||
|
Most recently, we updated our experience (up |
|
|
|
|||||
|
to 2006) to include a total of 50 patients with ONSM |
|
BrainLAB technique (Barcelona, Spain) |
||||||
|
(manuscript in preparation). Follow-up data were avail- |
|
Since 2000 this technique has been available at de- |
||||||
|
able for 38 patients (one treated to both eyes), with 12 |
|
|||||||
|
lost to follow up. Five patients had no light perception |
|
|
D |
|||||
|
|
partmentsPROOFSof Radiation Oncology of Centro Médico |
|||||||
|
in the involved eye on presentation (one lost to FU). |
|
Teknon-CMT, and Catalan Institute of Oncology-ICO, |
||||||
|
Among the remaining 34 patients with vision on pre- |
Eboth in Barcelona, Spain. |
|||||||
|
sentation, 20 (59%) experienced improvement in visualt |
|
Radiation therapy planning was done in several |
||||||
|
acuity and/or visual fields and 11 (32%) had stableCvi- |
|
phases: |
||||||
|
sion, for a total of 31/34 (91%) preserving vision.EThree |
|
1. Immobilization with triple thermoplastic mask |
||||||
|
patients (9%) had worse vision, in one case attributedR |
to |
|
|
(Figs. 10.8a,b–10.11a,b). Material for positioning is |
||||
|
tumour progression. One of the two remainingR received |
|
|
composed by head resting-place that includes head- |
|||||
|
SRT with the BrainLab system. |
|
CO |
|
|
|
rest, mask ring, screws for fixing vertical posts and |
||
|
|
N |
|
|
|
cam locks to put into cube for checking coordinates. |
|||
|
Two cases below illustrate an improvement in visual |
|
|
||||||
|
fields (Fig. 10.6) and an early visual acuity improvement, |
|
|
The non-invasive triple mask (top, rear, and middle |
|||||
|
u |
|
|
|
|
mask) enables precise and easy repeatable patient |
|||
|
occurring during the SRT course and within 3 months |
|
|
||||||
|
from SRT completion (Fig. 10.7). Such an early effect is |
|
|
fixation. The mask of thermo-transformable material |
|||||
|
not rare and it is difficult to explain biologically. |
|
|
|
is individually moulded for each patient and secured |
||||
|
|
|
|
|
|
|
to the mask ring (BrainLAB 2000; Villà et al. 2000; |
||
|
|
|
|
|
|
|
Brell et al. 2006). Mask should be heated in water |
||
|
|
|
|
|
|
|
to 70–80 °C. Different steps are needed to mould |
||
|
|
|
|
|
|
|
the entire mask. Patient’s head is left and snap the |
||
|
|
|
|
|
|
|
mask onto the upper side of the vertical posts and |
||
|
|
|
|
|
|
|
put down onto the headrest. In approximately 1 min |
||
|
|
|
|
|
|
|
mask material is hardening. After that, middle mask |
||
|
|
|
|
|
|
|
is placed in the centre of the middle’s face, carefully |
||
|
|
|
|
|
|
|
stretched. A T-shaped form nose bridge mould is |
||
|
|
|
|
|
|
|
added to the middle mask using rolled loose pellets |
||
|
|
|
|
|
|
|
after heating to optimize head fixation. The next step |
||
|
|
|
|
|
|
|
is to place the top mask centrally over the patient’s |
||
|
Fig. 10.6. Humphrey automated perimetry (24-2 central |
|
|
face ensuring that the curve in the mask is placed |
|||||
|
threshold) of left visual field in patient with left ONSM at pre- |
|
|
towards the patient’s mouth, but does not cover it. |
|||||
|
treatment (left) and at 11 months after SRT (right) |
|
|
|
Top mask is secured by clips. Different clips and |
||||
978-3-540-77557-7_1_2008-08-06_1
Stereotactic Radiation Therapy in Primary Optic Nerve Sheath Meningioma |
111 |
|
|
a
b |
N |
|
|
|
u |
Fig. 10.9. Head resting-place at time of treatment at coach position before starting RT session
Fig. 10.8a,b. Immobilization system – material for positioning and head fixation.
aHead resting-place: 1 – headrest, 2 – mask ring, 3 – screws, 4 – vertical posts, 5 – cam locks.
bMask system. Courtesy
of BrainLAB, Heimstetten,
Germany
Fig. 10.10. Head fixation using a triple thermo-plastic mask at time of treatment. Arrow shows an additional dental support strip for superior maxillary fixation
978-3-540-77557-7_1_2008-08-06_1
112 B. Jeremić, M. W. Wasik, S. Villà, F. Paulsen, G. Bednarz, D. Linero and M. Buchgeister
a |
b |
Fig. 10.11. a Head fixation using a triple thermo-plastic mask |
detected. b Lenses defined on each control CT scan (drawn in |
at time of treatment. Arrow shows a plastic clip (with five dif- |
different colours) and the respective lenses defined on the plan- |
ferent thickness from 0 mm to 4 mm). It permits a comfort- |
ning CT after CT-to-CT skull registration (Miralbell et al. |
able positioning for every patient regarding change of weigh |
2007) |
(for corticosteroids or malnutrition). No errors in precision are |
|
spacers are needed to adapt size and head anatomy |
|
|
and projected on to the respective CT sets. CT scans |
|||
for every patient and fix rear mask to top mask. An |
|
|
are used for dosimetric calculations. |
|||
additional dental support strip for superior maxil- |
|
D |
PROOFSDefinition of target volumes (GTV=CTV, and |
|||
|
|
|
||||
lary fixation is added to improve its quality. |
|
|
|
PTV) could be done in any of images (only CT scan |
||
Position of ocular balls. Eyes should be closed |
E volume definition is very useful in some patients; |
|||||
for simulation and treatment. Patients are requiredt |
|
see Fig. 10.12). GTV and CTV are defined as the |
||||
to close gently both eyes on MRI scan and onCCT |
|
|
whole optic nerve due to the difficulty to separate |
|||
scan, and for every session thereafter. WithEthis |
|
|
tumour itself of the rest of nerve in many cases. PTV |
|||
simple movement, we reported that marginsR |
of |
|
|
is defined with a margin of 3 mm (Miralbell et al. |
||
3 mm around the target may be necessaryR to safely |
|
|
2007). As a rule, all the following OARS have to be |
|||
|
CO |
|
|
|
defined: retina, contra-lateral optic nerve, chiasm, |
|
treat these tumours under ideal set-up conditions. |
|
|
||||
N |
|
|
|
lens, brain-stem, lachrymal gland, and pituitary. |
||
Experience from ocular melanoma was translated |
|
|
||||
to ONSM (Miralbell et al. 2007). As can be seen |
|
3. |
Dosimetry. Any of the facilities from TPS could be |
|||
u |
|
|
|
|
used such as conventional circular arc radiosurgery |
|
in Fig. 10.11, lenses for ipsilateral affected eye was |
|
|
||||
used to be defined on each control CT scan and the |
|
|
(RS), dynamic arc RS, conformal RS using multiple |
|||
respective lenses defined on the planning CT after |
|
|
static shaped beams (Fig. 10.13), and IMRS imple- |
|||
CT-to-CT skull registration. |
|
|
|
|
mented by either static or dynamic micro multi-leaf |
|
2. Co-registration of CT and MRI. After cranial immo- |
|
|
collimator (mMLC) techniques (Fig. 10.14). The |
|||
bilization, all patients underwent a planning CT scan |
|
|
so-called m3 mMLC “moulds” target shape in any |
|||
with fiducial rods attached to the head frame. CT im- |
|
|
angle and field (beam eye view). |
|||
ages are obtained from the scalp vertex through the |
|
4. Dose. Prescribed total dose ranges between 50 and |
||||
brain using 2–3 mm thick slices (acquisition time is |
|
|
54 Gy at ICRU point, 25–30 fractions, 1.8–2 Gy per |
|||
of 30–40 s) and transferred to the treatment plan- |
|
|
fraction, once a day (Fig. 10.15). |
|||
ning system (TPS), BrainScan 5.1 (BrainLAB A.G., |
|
5. |
OARS. Contra-lateral optic nerve, chiasm, lens, |
|||
Heimstetten, Germany). Contrast for CT is used in |
|
|
lachrymal gland, pituitary, brain-stem, and retina |
|||
some cases. CT to MRI registration is performed for |
|
|
are systematically drawn (Fig. 10.15).Optimal or- |
|||
each patient by automatic alignment of bone struc- |
|
|
gan dose constraints are as follows: retina: 50 Gy; |
|||
tures on the two image sets. Target volumes and or- |
|
|
lens: 9 Gy; optic nerve and chiasm: 55 Gy; lacrymal |
|||
gans at risk (OARs) are defined on the MR images |
|
|
gland: 30 Gy |
|||
978-3-540-77557-7_1_2008-08-06_1
Stereotactic Radiation Therapy in Primary Optic Nerve Sheath Meningioma |
113 |
|
|
Fig. 10.12. Isodoses distribution on the PTV. The patient was planned using the CT scan
Fig. 10.14. Image of the m3 micromultileaf collimator (beam eye view)
Fig. 10.13.PROOFSIn this figure it can be seen an example of five fix fields conformed by micromultileaf m3 collimator. The colli-
sion map to guarantee no accidents at the treatment set up can also be observed
Fig. 10.15. Dose Volume Histogram (DVH) for GTV and PTV, and most relevant organs at risk for the specific case
978-3-540-77557-7_1_2008-08-06_1
114 B. Jeremić, M. W. Wasik, S. Villà, F. Paulsen, G. Bednarz, D. Linero and M. Buchgeister
Dose Volume Histogram (DVH) must always be done and displayed for GTV, CTV and PTV, and for most relevant organs at risk for every specific case (Fig. 10.15).
Treatment was performed using a radiosurgery-ded- icated 6-MV X-ray beam linear accelerator with a built-in m3 mMLC (Figs. 10.14 and 10.16) (Novalis®, BrainLAB, Heimstetten, Germany). It was installed at Centro Médico Teknon in Barcelona in 2000. This treatment system is able to operate in several modalities (see above). For treatment set-up a cube for checking coor-
dinates is used every fraction to assure minimal isocenter error and good quality assurance (Fig. 10.17). This cube enables one to check the origin of the coordinates (coordinates 0,0,0) at the beginning of set-up and to move to the PTV coordinates.
Three different laser projections (two laterals and one superior-saggital) are projected on coordinates cube and on patient mask (Figs. 10.18 and 10.19). In relation to final dosimetry, different coach and gantry angles are needed to accomplish treatment agreed between physicians and physicists. Coach position must be checked inside the bunker (Fig. 10.16).
|
|
|
t |
|
|
|
C |
Fig. 10.16. In relation to final dosimetry, different coach and |
|||
|
|
E |
|
gantry angles are needed to accomplish treatment agreed be- |
|||
|
|
R |
|
tween physicians and physicists. Treatment position. Table and |
|||
gantry rotation for a specific treatment field |
R |
|
|
CO |
|
|
|
Fig. 10.18. Triple room lasers for checking patient position: lateral laser (A) and superior (saggital) laser (B)
Fig. 10.17. Cube for checking the origin coordinates (coordinates 0,0,0) and the PTV coordinates (arrow)
Fig. 10.19. Triple room lasers for checking patient position. Simulation of the isocenter on the centre of the orbit
978-3-540-77557-7_1_2008-08-06_1
|
Stereotactic Radiation Therapy in Primary Optic Nerve Sheath Meningioma |
115 |
||
|
|
|
|
|
10.3.1.3 |
|
|
mobilisation systems deal with the whole treatment |
|
university of tuebingen, Germany Approach |
|
unit including a visualisation tool (CT) at the LINAC |
|
|
At Tuebingen, conformal radiotherapy of optic nerve |
|
and a robotic table also being able to compensate for |
|
|
|
rotational errors. |
|
||
sheath meningioma has been performed with 6-MV |
|
For the approach described in the following section, |
|
|
photons and a conventional fractionation scheme at a |
|
a rigid relocatable immobilisation mask system with a |
|
|
linear accelerator (LINAC) employing a non-invasive |
|
mean accuracy of 0.8 ± 0.6 mm is used. In an analysis of |
|
|
rigid mask immobilisation system designed at the Ger- |
|
our first patients 95% of all absolute measures were less |
|
|
man Cancer Research Center, Heidelberg, since 1993 |
|
than 2.8 mm for transition to the LINAC and 4.6 mm |
|
|
(Schlegel et al. 1992; Becker et al. 2002a). Treatment |
|
during treatment (Kortmann et al. 1999). The isocen- |
|
|
planning precedes an interdisciplinary board discussing |
|
ter setup is performed with a stereotactic localization |
|
|
the indication and target extension for treatment. The |
|
system described in Becker et al. (2002a) using ste- |
|
|
target volume comprises the gross visible optic nerve |
|
reotactic coordinates. Stereotactic coordinates are used |
|
|
sheath tumour. If this is not clearly distinguishable, the |
|
for the transfer of the isocenter to the patient within the |
|
|
whole optic nerve (GTV) covering the anatomical re- |
|
immobilisation mask. The process of treatment plan- |
|
|
gion of ophthalmological functional deficits, enlarged |
|
ning starts with the building of the special removable |
|
|
by necessary safety margins of the used mask immo- |
|
immobilisation mask system. The mask is made of cast |
|
|
bilisation system represents the planning target volume |
|
material. For its creation the patient lies supine on a |
|
|
(PTV). Organs at risk (OARs) in close vicinity such as |
|
treatment couch with his head resting in an extension |
|
|
chiasm, optical nerve, eye globes, lenses, brain stem or |
|
made of two curved wooden plates around which the |
|
|
the brain itself are segmented in the planning computed |
|
cast material is rolled (Fig. 10.20). The extension is |
|
|
tomography (CT) slices. The treatment planning is |
|
necessary to avoid dosimetric disturbances due to the |
|
|
performed with a commercial planning system (Helax |
|
treatment couch for posterior entry portals or collision |
|
|
TMS) employing non-coplanar, wedged and individu- |
|
between gantry and couch. This enables a wide range |
|
|
ally shaped small treatment portals. A fractionation of |
|
of non-PROOFScoplanar beams. After hardening of the material |
|
|
5 × 1.8 Gy/week up to 54 Gy is used. The immobilisation |
|
(about 30–45 min) the mask is cut from chin to above |
|
|
of the patient to treat this vulnerable region has to be |
|
D |
|
|
Ethe ear region to allow the patient to leave and re-en- |
|
|||
optimised for the correct daily beam application. Sevt- |
ter the mask (Fig. 10.21) with reasonable comfort. For |
|
||
eral principles can be used to achieve this goal. A Crela- |
|
planning and treatment the mask is closed with simple |
|
|
tively simple method is the usage of a rigid maskEsystem |
|
fixation locks at each side. The patient holds an emer- |
|
|
with well known immobilisation errors thatRare taken |
|
gency trip wire to be able to release the mask fixation |
|
|
into account in the definition of the PTV. TheRindividual |
|
locking (Fig. 10.20). |
|
|
set-up control is described below. More advanced im- |
|
|
|
|
|
CO |
|
|
|
N |
|
|
|
|
u |
|
|
|
|
Fig. 10.20. Mask made of casting material rolled around wood- |
Fig. 10.21. Jaw of the mask and patients’ entrance into the |
en plates, removable fixation for the patients’ emergency exit |
mask |
978-3-540-77557-7_1_2008-08-06_1
116 |
B. Jeremić, M. W. Wasik, S. Villà, F. Paulsen, G. Bednarz, D. Linero and M. Buchgeister |
||
|
|
|
|
|
During treatment planning a diagnostic MRI and |
the beams’ eye view function of the RTP. The treatment |
|
|
the planning CT are fused (e.g. by mutual information |
plan is iteratively optimized to achieve a dose distribu- |
|
|
algorithms) in the radiation treatment planning system |
tion according to the guidelines defined by the ICRU |
|
|
(RTP) and checked by an experienced radiation oncolo- |
50 report. PTV and OARs define the geometry of each |
|
|
gist. A stereotactic localisator, that is mounted over the |
field such that 95% of the prescribed dose surrounds |
|
|
fixation mask (Fig. 10.22) defines the stereotactic coor- |
the PTV. An experienced treatment planning team usu- |
|
|
dinate system for the patients’ anatomy inside the mask. |
ally achieves a homogeneous dose distribution for the |
|
|
The planning CT includes the whole head from the top |
PTV. The dose to brain stem, chiasm or optical nerves |
|
|
of the scull to the neck to allow for the planning of non- |
should not exceed 54–55 Gy in 1.8-Gy fractions, the |
|
|
coplanar treatment beams and to estimate the beam |
dose to the other OARs being as described above in this |
|
|
direction inside the body (Fig. 10.23). The slice thick- |
chapter. Usually 5–6 wedged fields are used. The posi- |
|
|
ness is in the range of 2–3 mm in the region of the PTV |
tion of the isocenter for treatment is defined within the |
|
|
to get adequate resolution of the different small sized |
stereotactic localisator at the CT. Three translations are |
|
|
organs. As the planning CT and a high resolution MRI |
given to move the patient from the stereotactic coordi- |
|
|
is co-registered for target volume definition, a contrast |
nate (0;0;0) to the coordinates of the isocenter (X;Y;Z) |
|
|
media enhanced planning CT is not also necessary. Sec- |
(Fig. 10.25) at the set-up for treatment. The z-coordinate |
|
|
ond, due to the rigid mask system, there is a higher risk |
is defined by the distance “A” of the metal markers at the |
|
|
for severe complications in case of allergic reactions |
surface of the stereotactic localisation tool (Figs. 10.22 |
|
|
3.6 Gy, the PTV is reduced by adding only 2 mm safety |
trolled PROOFSbefore treatment by comparison of the block’s |
|
|
to the contrast media when such a CT is taken. After |
and 10.25). Two orthogonal verification beams of stan- |
|
|
co-registration of the planning CT and the MRI, tar- |
dardized field size of 8 × 8 cm2 are created and digital |
|
|
get volumes (GTV, organs at risk) are delineated. The |
reconstructed radiographs (DRR) are printed for fol- |
|
|
PTV is generated by adding 5 mm to the GTV for the |
lowing setup verifications at the LINAC. Individualized |
|
|
treatment plan that is used for the first 28 fractions up |
shielding is achieved by usage of conventional shielding |
|
|
to 50.4 Gy (Fig. 10.24). For the boost of an additional |
blocks made of MCP96. Every shielding block is con- |
|
|
margin around the GTV. |
|
D |
|
|
light field shape at the LINAC with the scaled beam’s |
|
|
Optimal beam angles are determined during the |
Eoutline printed on paper (Fig. 10.26). The deviation of |
|
|
|
C |
|
|
radiation treatment planning process with the help oftthe resulting field has to be in a clinical acceptable range |
||
|
E |
|
|
|
R |
|
|
Fig. 10.22. Planning stereotactic localisation tool mounted over the mask; diagonal radiopaque lines with defined distance “A”
Fig. 10.23. Isodose distribution in a sagittal reconstruction estimating the bodies distribution
978-3-540-77557-7_1_2008-08-06_1
